TY  - GEN
AU  - Suleiman,Ahmed A
AU  - Khatri,Amit
AU  - Minocha,Mukul
AU  - Othman,Ahmed A
TI  - Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn's Disease: Analyses of Phase I and II Trials
SN  - 1179-1926
PY  - 2020///0522
KW  - Administration, Intravenous
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Biological Availability
KW  - Biological Variation, Population
KW  - drug effects
KW  - Body Weight
KW  - Crohn Disease
KW  - blood
KW  - Female
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Interleukin-23
KW  - antagonists & inhibitors
KW  - Male
KW  - Middle Aged
KW  - Models, Biological
KW  - Psoriasis
KW  - Serum Albumin
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s40262-018-0704-z
ER  -